|  | pg per well | X 100 |
---|
Sample | GVBD (%) | E2 | T | DHP | T/E2 | DHP/E2 |
---|
FPE
b
| 38 ± 7 | 5,850 ± 2,000 | 264 ± 48 | 332 ± 68 | 4.5 | 5.7 |
FPE
c
| 40 ± 5 | 4,450 ± 2,000 | 240 ± 56 | 312 ± 48 | 5.4 | 7.0 |
I-1
d
| 12 ± 12 | 3,150 ± 1,204 | 147 ± 53 | 126 ± 18 | 4.7 | 4.0 |
II-8
d
| 29 ± 8 | 3,300 ± 450 | 145 ± 14 | 139 ± 49 | 4.4 | 4.2 |
III-10
d
| 4 ± 3 | 2,120 ± 701 | 60 ± 60 | 43 ± 15 | 2.8 | 2.0 |
V-19
d
| 26 ± 15 | 4,483 ± 393 | 271 ± 23 | 339 ± 91 | 6.0 | 7.6 |
- aResults presented as means ± SEM derived from three chromatographic series. In the absence of added gonadotropin, no GVBD took place and T- and DHP-production were undetectable, while E2-production averaged 1,150 pg per well. The latter baseline value was subtracted from the induced E2 data to provide the indicated values for E2. bThawed, immediately added to L-15 medium, and tested for activity at a concentration of 0.5 pit. equiv./well (0.25 pit. equiv./ml). cThawed, stored for up to a week at 4°C, dialyzed overnight against distilled water, dried by vacuum centrifugation, reconstituted with L-15 medium, and tested for activity at a concentration of 0.5 pit. equiv./well. dRoman numerals refer to portions of the chromatofocusing runs (Fig. 4) while Arabic numerals refer to active fractions found after subsequent HIC (Fig. 5).